Notifiable Share Interest in

RNS Number : 9658I

GlaxoSmithKline PLC

22 March 2010

 



Notifiable Share Interest in OctoPlus N.V.

GlaxoSmithKline plc ("GSK") announces that on 18 March 2010 GSK sold 25,907 ordinary shares of OctoPlus N.V. ("OctoPlus"), a pharmaceuticals product and drug delivery company located in the Netherlands, and whose shares are traded on Euronext Amsterdam.

GSK's interest, which is held by S.R. One, Limited,a wholly owned US-registered subsidiary of GSK ("S.R.One"), now comprises 5,003,710 ordinary shares or 14.9% of OctoPlus. The calculation is based on a total of 33,435,432 shares outstanding in OctoPlus.  This decreased interest became disclosable under the rules of the Dutch Financial Supervision Act upon falling below 15% of the issued share capital of OctoPlus, and an announcement regarding this decreased holding is due to be made to the Netherlands Authority for the Financial Markets ("AFM") on 22 March 2010.

Simon Bicknell

Company Secretary

22 March 2010

 

END

 

 

HOLUUSVRRKAOUAR